This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Warren A, Langley JM, Thomas W, Scott J.Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: a successful provincial respiratory syncytial virus prophylaxis program. Canadian Journal of Cardiology 23: 463-466, No. 6, 1 May 2007
Rights and permissions
About this article
Cite this article
Optimising palivizumab use in infants with heart disorders. Pharmacoecon. Outcomes News 531, 9 (2007). https://doi.org/10.2165/00151234-200705310-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705310-00017